RGLS : Summary for Regulus Therapeutics Inc. - Yahoo Finance

U.S. Markets closed

Regulus Therapeutics Inc. (RGLS)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.650.00 (0.00%)
At close: 4:00 PM EST
People also watch:
PTCTPTLACEMPEPZMOMED
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.65
Open2.55
Bid2.50 x 300
Ask2.90 x 400
Day's Range2.42 - 2.70
52 Week Range2.13 - 10.18
Volume363,905
Avg. Volume432,257
Market Cap140.25M
Beta2.40
PE Ratio (TTM)-2.02
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    Regulus Announces New Drug Development Candidates

    LA JOLLA, Calif., Dec. 6, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced two new drug development candidates at its R&D day, held in New York. "We are delighted to announce the addition of two new drug candidates to our growing portfolio of potential microRNA therapeutics.

  • PR Newswire15 days ago

    Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016

    LA JOLLA, Calif., Nov. 22, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will host a R&D day on Tuesday, December 6, 2016 from 8:30 a.m. to 11:30 a.m. EST in New York City where it plans to announce new development candidates. Interested parties may access a live audio webcast and slides of the presentations on the investor section of Regulus' website at www.regulusrx.com beginning at 8:30 a.m. EST.

  • Capital Cubelast month

    ETF’s with exposure to Regulus Therapeutics, Inc. : November 4, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Regulus Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to RGLS-US. Comparing the performance and risk of Regulus Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)